InvestorsHub Logo
Followers 4
Posts 133
Boards Moderated 0
Alias Born 09/26/2018

Re: None

Thursday, 08/11/2022 6:14:14 AM

Thursday, August 11, 2022 6:14:14 AM

Post# of 429470
This would be another huge indication for Vascepa. Not a difficult pilot study to run, and all you would have to look at is the photographic progression of macular degeneration. Meanwhile in addition to preventing these patients from going blind, you also avert serious CVD events.

https://www.medpagetoday.com/meetingcoverage/asrsvideopearls/100153
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News